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Introduction 
 
 
 
1 INTRODUCTION 
Anaemia is the blood disorder characterized by reduction in the total number 
of red blood cells, haemoglobin concentration and packed cell volume
[1]
. 
Haemoglobin is a main part of RBC that makes the blood cells red which binds with 
oxygen. There is an insufficient oxygen supply to the body in case of anaemia. The 
reduction in Red Blood C  ells results in impaired oxygen delivery to tissues, giving 
rise to physiologic consequences of tissue hypoxia, fatigue, weakness, dizziness, 
headache,  numbness or coldness in  hands and feet, low body temperature, pale skin, 
rapid or irregular heartbeat, shortness of breath, chest pain and irritability
[2]
.
 
The normal level of haemoglobin is generally different for men and women. 
For men, anaemia is typically defined as haemoglobin level of less than 13.5g/100ml 
and in women as haemoglobin of less than 12.0 grams/100ml
[3]
.Anaemia caused by 
blood loss, decreased red blood cell production, destruction of red blood cell and low 
haemoglobin level
[4]
. 
Statistics
 
Anaemia is the major health problem and its needs urgent treatment. WHO 
report stated that, In 1992-the overall prevalence of anaemia is about 42% in 
developing countries. Among there, 51% are pregnant women and 41% are non- 
pregnant women. This report stated that half of the women are from the South East 
Asia are anaemic. In 1993-2015, the overall prevalence is about 25%.  It includes 
65.5%- preschool children, 48.2%-pregnant women, 45.7%- non pregnant women 
were estimated to have anaemia. In adulthood female has more prevalence and more 
severity of anaemia, whereas in children male children had higher prevalence to 
anaemia than female
[5]
. 
 In India, anaemia became the major public health challenge that attacks 
preschool children and women at reproductive age. In 2002-2004-DLHS (District 
Level Health Service) reported that, 98% of adolescent girls and 96% of pregnant 
women are suffered from anaemia. In 2005-2006- NFHS (National Family Health 
Survey) reported that 24% of men are also found to have anaemia due to low level of 
haemoglobin than normal level.  Even though the government carries out several 
interventions, Anaemia is still remains endemic
[5]
.
 
1934 George Richards Minot and his assistant, William Parry Murphy: 
shared the Nobel Prize for their discovery about pernicious anaemia could be 
successfully treated with large quantities of raw liver in patient‟s diets[6]. 
WHO definition for anaemia 
Anaemia is a condition in which the number of red blood cells or their oxygen 
carrying capacity is insufficient to meet physiologic needs, which vary by age, sex, 
altitude, smoking and pregnancy status.In its severe form, it is associated with fatigue, 
weakness, dizziness and drowsiness. Pregnant women and children are particularly 
vulnerable
[7]
. 
 CLASSIFICATION 
RBC indices are important in the assessment of anaemia.In general, two 
approaches are used to identify the likely cause of, alterations of the RBC indices and 
manual examination of a blood smear
[2]
. The first step in the classification of is to 
assign the type based on the average size of the red blood cells. If the MCV (Mean 
Corpuscular Volume) is < 80 fL it is considered microcytic, >100 fL macrocyticand 
the values between these two are normocytic
[8]
.
 
 
Macrocytic anaemia 
Abnormal nucleic acid production in the RBC precursor cells such as in B12 
and folate defciency result in macrocytosis. When the MCV is greater than 115fL the 
anaemia is called megaloblastic.
 
Macrocytosis is a characteristic of juvenile RBC. Thus, often haemolytic 
anaemias, which are associated with increased production and release of red cells 
(reticulocytosis) are macrocytic
[8]
. 
Microcytic anaemia 
This anaemia is most often accompanied by hypochromasia (MCH of less than 
27pg).  
Normocytic anaemia 
This is a rather large and somewhat ill defined group of disorders in which the 
differential diagnosis can often be narrowed by careful examination of the blood film. 
Detection of a characteristic morphological abnormality such as tear drop cells, sickle 
cells, spherocytes
 [8]
.
 
CAUSES OF ANAEMIA 
1. Destruction of RBC 
It occurs when red blood cells are being destroyed pre maturely. The normal 
lifespan of RBCs is 120 days; in haemolytic anaemia, it‟s much shorter and the bone 
marrow (the soft, spongy tissue inside bones that makes new blood cells) simply 
cannot keep up with the body‟s demand for new cells. This can happen for a variety of 
reasons. Sometimes, infections or certain medications – such as antibiotics or 
antiseizure medications are also cause anaemia
[2]
.
 
2. Blood loss 
Blood cells naturally die and are reproduced in the body. There are times when 
the production of the red blood in the body cannot cope with the demand for it. This 
usually happens during times when there is severe issue of blood like in the case of 
women having irregular menstruation. Internal bleeding like in the case of people with 
ulcer also contributes to the abnormal discharge of blood.  As a rule, when a red blood 
cell is destroyed, it should be a replaced. The body is capable of producing red blood 
cell of its own. Production takes place in the bone marrows. There are times when the 
bone marrow lacks the ability to produce the right amount of red blood. In this case 
the red blood cells count decreases, which results in a certain type of anaemia
 [1]
. 
3. Other causes for anaemia 
3.a Iron Deficiency Anaemia (IDA)
 
 As the name implies this type of anaemia is caused by the lack of iron in the 
body. Iron is used in the production of red blood cells in the body. When a person 
lacks in iron, the production of red blood cells is affected.
 
A person can have a low iron level because of blood loss. In women, iron and 
red blood cells are lost when bleeding occurs from very heavy and long periods, as 
well as from childbirth. Women also can lose iron and red blood cells from uterine 
fibroids, which can bleed slowly. Other ways iron and red blood cells can be lost 
include: 
• Ulcers, colon polyps or colon cancer 
• Regular use of aspirin and other drugs for pain 
• Infections 
• Severe injury 
• Surgery 
Eating foods low in iron also can cause IDA. Meat, poultry, fish, eggs, dairy 
products or iron-fortified foods are the best sources of iron found in food. Pregnancy 
can cause IDA if a woman doesn‟t consume enough iron for both her and her unborn 
baby. Some people have enough iron in their blood, but have problems absorbing it 
because of diseases, such as Crohn‟s disease and Celiac disease or drugs they are 
taking
 [8]
. 
3.b Vitamins deficiency anaemia
 
Vitamin B12 is a product of an enzyme secreted in stomach. Deficiency of 
Vitamin B12 and folic acid results in megaloblastic anaemia. It is characterized by 
presence of large blood cell precursor in bone marrow and therefore called as 
maturation factor. Some people cannot produce enough Vitamin B12 and 
consequently could not produce enough red blood cells and causes nerve damage.This 
type of anaemia occurs most often in people whose bodies are not able to absorb 
vitamin B12 from food because of an autoimmune disorder. It also can happen 
because of intestinal problems
 [9]
.
 
Vitamin B12 is found in foods that come from animals and cereals. Folic acid 
supplements (pills) can treat this type of anaemia. But, folic acid cannot treat nerve 
damage caused by a lack of vitamin B12.  Not getting enough vitamin B12 can cause 
numbness in legs and feet, problem in walking, memory loss, and problem in eye 
sight
 [9]
. 
 
3.c Folate deficiency anaemia 
 This type of anaemia can occur if the enough folate is not consumed or having 
problems in absorbing vitamins. It also may occur during the third trimester of 
pregnancy, when the body needs extra folate. Folate is a Vitamin B found in foods 
such as leafy green vegetables, fruits, and dried beans and peas, fortified breads, pastas 
and cereals
 [9]
. 
4. Anaemia caused by kidney dysfunction 
Some diseases can hurt the body's ability to make red blood cells. For 
example, anaemia is common in people with kidney disease. Their kidneys can't make 
enough of the hormones that signal the body to make red blood cells. Plus, iron is lost 
in dialysis (what some people with kidney disease must have to take out waste from 
the blood). 
 Erythropoietin is a factor produced by the kidney that stimulates erythrocyte 
production and various other cells to produce haemopoietic growth factor like colony 
stimulating factors which regulate the production of platelets, leucocytes and other 
blood cell types. Colony-stimulating factors (CSFs) stimulate blood cell progenitor 
cells to proliferate and differentiate
[13]
.
 
5. Anaemias caused by inherited blood disease 
Anaemia also caused by untreated blood disorders.  Here are some types, 
5.a Sickle cell anaemia
 
The red blood cells of people with sickle cell disease are hard and have a 
curved edge. These cells can get stuck in the small blood vessels, blocking the flow of 
blood to the organs and limbs. The body destroys sickle red cells quickly. But, it can't 
make new red blood cells fast enough
 [8]
.
 
5.b Aplastic anaemia 
 
This is a rare blood disorder in which the body stops making enough new 
blood cells. All blood cells like red blood cells, white blood cells and platelets are 
affected. Low levels of red blood cells leads to anaemia. With low levels of white 
blood cells, the body is less able to fight infections. With too few platelets, the blood 
can‟t clot normally. This can be caused by many things: 
• Cancer treatments (radiation or chemotherapy) 
• Exposure to toxic chemicals (like those used in some insecticides, paint 
and household cleaners) 
• Some drugs (like those that treat rheumatoid arthritis) 
• Autoimmune diseases (like lupus) 
• Viral infections 
• Family diseases passed on by genes[8]. 
5.c Thalassemia
 
People with thalassemia make less haemoglobin and fewer red blood cells 
than normal. This leads to mild or severe anaemia. One severe form of this condition 
is Cooley‟s anaemia[11].But the major cause is bone marrow depression, the 
destruction of red blood cells and loss of blood though internal bleeding or abnormal 
menstrual discharge
[8]
. 
 
 
 
HAEMOLYTIC ANAEMIA 
Hemolytic anaemia is the destruction of red blood cells from the circulation  
before their normal lifespan of 120 days
[1]
.
 
There are two mechanisms of hemolysis. Intravascular hemolysis is the 
destruction of red blood cells in the circulation with the release of cell contents into 
the plasma. Mechanical trauma from a damaged endothelium,complement fixation 
and activation on the cell surface and infectious agents may cause direct membrane 
degradation and cell destruction.
 
The more common extravascular hemolysisis the removal and destruction of 
red blood cells with membrane alterations by the macrophages  of the spleen and 
liver.  Circulating blood is filtered continuously through thin walled splenic cords into 
the splenic sinusoids.
 
Role of G6PD in red blood cell 
 Reduced activity of Glucose 6-phosphate dehydrogenase impairs with the cell 
to form NADPH that is essential for the maintenance of reduced glutathione level. 
This results in decrease in the cellular detoxification of free radicals and peroxides 
formed within the cell and its also helps to maintain the sulphydryl group. Oxidation 
of this sulphydryl groups leads to the formation of denatured proteins that form 
insoluble masses (Heinz bodies) that attached to red blood cell membrane. Additional 
oxidation of membrane proteins causes the red blood cells to be rigid and they are 
removed from the circulation by macrophages in the spleen and liver.
 
G6PD deficiency is the major cause for hemolytic anaemia and it is due to 
inability to detoxify oxidizing agents. Oxidant drugs like sulphamethoxazole, 
chloramphenicol and antipyretics like acetaminophen cause hemolytic anaemia. In 
inflammation associated with the infection there is a generation of free radicals in 
macrophages, and cause oxiadative damage
[10]
.
 
Pyruvate kinase deficiency 
 Pyruvate kinase deficiency is the second most common cause after G6PD 
deficiency of enzyme deficiency related to hemolytic anaemia. 
 The normal, mature erythrocyte lacks mitochondria therefore it completely 
dependent on glycolysis for the production of ATP. This high energy compound is 
required to meet the metabolic needs of the red blood cell and also necessary for the 
maintenance of the biconcave flexible shape of the red blood cells, which allows the 
cells to squeeze through narrow capillaries.  
 The reduced rate of glycolysis leads to decreased ATP production. It further 
leads to alterations in the red blood cell membrane and leads to changes in the shape 
of the red blood cell and cause phagocytosis by the cells of the reticulo endothelial 
system, particularly macrophages of the spleen. The premature death and lysis of red 
blood cells results in haemolytic anemia.  Pyruvate kinase deficiency is restricted to 
erythrocytes and produce mild to severe chronic anaemia. The severity of the disease 
is depends upon the degree of the enzyme deficiency
[10]
.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 OXIDATIVE STRESS IN RBC 
 
The RBC‟s are the first cell to be affected by oxidative stress. As they pass 
through lungs they carry free radicals along with oxygen. The RBC‟s contain high 
level of cytoplasmic antioxidant both enzymatic and non enzymaticin order to protect 
the RBC from deleterious effect of oxidative stress.The α-tocopherol, ascorbic acid 
and reduced glutathione level are the major endogenous antioxidants. 
  αtocopherol protects he PUFA in the RBC membrane against lipid 
peroxidation. Ascorbic acid, a potent cellular antioxidant protects the cell membrane 
from oxidative damage and also regenerate oxidized α-tocopherol. Reduced 
glutathione in erythrocytes maintain haemoglobin in its native form.  
  ROS induced cell membrane damage allows the GSH to pass through the 
membrane causing depletion of GSH in the cytoplasm of RBC. As the erythrocytes 
have no nucleus and ribosome and cannot regenerate GSH and enzyme thus becoming 
vulnerable to oxidative damage
 [10]
. 
  Glutathione maintains the reduced state of sulphydryl groups in proteins 
including haemoglobin. Oxidation of sulphydryl groups leads to the formation of 
denatured proteins that forms insoluble masses called as ‘Heinz bodies’ that attaches 
to cell membrane. Oxidation of the cell membrane causes rigidity of the RBC which 
are removed from the surface by macrophage in the spleen and liver. Higher degree of 
oxidation ultimately results in haemolysis of RBC‟s. Reticulocytes are visualized in 
the peripheral blood as polychromatophilic red cell which is the cause for 
macrocytosis
[11]
. 
  
 
 
 
  
Figure 1shows the structural changes in the RBC due to oxidative haemolysis 
 
1. Normal red blood cell without oxidative stress. 
  
2. Irregularly contracted and crenated cells- due to altered cell membrane 
integrity
[12]
. 
 
3. Presence of Heinz bodies- due to denatured haemoglobin
[11]
. 
 
 
 
                             
    
      Normal RBC‟s without oxidative stress                     RBC‟s with crenated edges 
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 SIGNS AND SYMPTOMS OF ANAEMIA
[7] 
 
The symptoms of anaemia are fatigue, weakness, dizziness, headache 
increased thirst numbness or coldness in  hands and feet, low body temperature, pale 
skin, rapid or irregular heartbeat, shortness of breath, chest pain and irritability. 
RISK FACTORS
[7] 
Infants and children, premenopausal women, elder persons, alcoholism, 
iron-poor diets, chronic or critical illnesses, excessive exercise and pregnancy. 
REATMENT OF ANAEMIA 
ANTI ANAEMIC DRUGS
 
    Many treatment options are available for anaemia, but the primary choice is 
antianaemic drugs. Which treatments are used depends upon the type, location and 
grade of the anaemia as well as the person's health and wishes. The treatment intent 
may be curative or not curative
[13]
.
 
Preparationof Iron 
Oral preparations 
 Ferrous sulphate                                                              
 Ferrous gluconate 
 Ferrous fumarate 
 Carbonyl ferric hydroxide 
 Carbonyl iron 
Parenteral preparations 
 Iron sorbitol citric acid complex 
 Iron dextran 
 Ferrous sucrose and ferric carboxymaltose[14]. 
Ferrous Sulphate 
Ferrous sulphate contains 20%(hydrated salt) and 32%(dried salt) elemental 
iron. It is the oldest and cheapest iron preparation. 
Indications: Iron deficiency anaemia, blood loss related to pregnancy or GI bleeding 
(NSAIDs), hookworm infestation, or excess coffee. 
Iron Dextran  
 Iron dextran is one of the parenteral preparation of iron supplement. It can be 
administered by intravenously or intramuscularly. 
Indications 
 Patients with documented iron deficiency in whom oral administration 
is unsatisfactory or impossible (e.g. malabsorption syndrome, prolonged salicylate 
therapy, dialysis patients). 
 Seldom used now (newer orally effective agents including iron sucrose 
& ferric gluconate complex are most commonly used)
[8]
. 
Vitamin B12  
 Vitamin B12 is a cobalt containing compound and present in food of animal 
origin, such as meat, liver, egg, fish, etc. 
Indications 
 Used to treat or prevent deficiency of Vit B12.  
 The most common causes of Vit B12 deficiency are: 
 Pernicious anaemia (results from defective secretion of intrinsic factor 
by the gastric mucosal cells) 
 Fish tapeworm infection 
 Partial or total gastrectomy 
 Various intestinal disorders that impair absorption of Vit B12[9].  
 Folic acid  
 Folic acid is a combination of glutamic acid, para-aminobenzoic acid and pteridine 
nucleus. It is found in fresh leafy vegetables, liver, yeast, fruits etc. 
Indications 
 Treatment of megaloblastic anaemias due to a deficiency of folic acid 
as may be seen in tropical or non-tropical sprue, in anaemias of nutritional origin, 
pregnancy, infancy, or childhood 
 A reduced form of folic acid known as citrovorum factor (or 
leucovorin) is given to replenish endogenous folic acid in patients on methotrexate 
(which inhibits dihydrofolate reductase). Citrovorin (leucovorin) is better absorbed 
compared to folic acid
[9]
. 
Erythropoietin (Epoetin alpha) 
Indications 
 Chronic renal failure patients 
 Zidovudine-treated HIV-infected patients 
 Cancer patients on chemotherapy 
 Reduction of allogeneic blood transfusion in surgery patients. 
Erythropoietin deficiency can result from compromised renal function (its primary 
site of production). Erythropoietin deficiency results in a normocytic anaemia
[13][14]
. 
Treatment & side effects 
Based on the type of the anaemia, the treatment varies, those are Iron, Folic 
acid, Vitamin B12 supplements and erythropoietin are most commonly prescribed. 
Although these drugs have remarkable treatment, many of them have high incidence 
of adverse effects like nausea, abdominal pain, constipation or diarrhoea, fever, 
urticaria, bronchospasm, allergic sensitization even circulatory collapse and death also 
reported  in overdose of iron (1-2g)
[14]
.
 
Traditional treatment 
 Indigenous systems of medicine like Siddha, Ayurveda and Unani are mainly 
use medicinal plants for treatment of various ailments of the human beings and 
animals. With the development of these systems, the herbal plants are being sought 
after, both by clinicians and patients in search for cure of diseases. Herbal medicine is 
a form of complementary and alternative medicine and is becoming increasingly 
popular in both developing and developed countries
[15]
.  
 WHO has described traditional medicine as one of the surest means to achieve 
total health care coverage of the world‟s population.In pursuance of its goal of 
providing accessible and culturally acceptable health care for the global population, 
WHO has encouraged the rational use of traditional plant based medicines by member 
states and has developed technical guidelines for the assessment of herbal 
medicines
[16]
.
 
The herbal drugs have been used throughout the world and have raised greater 
attention in recent times, because of their diverse nature of curing diseases, safety and 
well tolerated remedies compare to the conventional medicines. Moreover the herbs 
with natural combinations of constituents as a whole are naturally occurring remedies 
which have proved to be more effective and safer than conventional medicines
[17]
.
 
 Herbs that are used as anti-anaemic agents with lesser side effects are 
Amaranthus paniculata, Amaranthus  spinosus, Basella rubra, Corriander sativum, 
Digella muricata, Eclipta alba, Hibiscus cannabis, Mentha piperita, Moringa olifera, 
Murraya koenigii, Solanum nigrum, Trigonella foeumgraecum
[4][18]
.  
Phyllanthus emblica Linn.,belonging to Phyllanthaceae well known as Nellikai in 
Tamil is an annual herbaceous plant. Mainly grown in India is used as a traditional 
healer of many ailment and it was revealed by various research works and has its own 
importance in Ayurveda to treat fever, inflammation peptic ulcer. Analgesic, 
digestive, hair tonic diuretic, anti tussive, cardio protective, chemo preventive, free 
radical scavenging activity, anti mutagenic, cancer, anti diabetic
[19][20]
.
 
Since no work done on Streptozocin induced anaemia in rats with the fruits of 
Phyllanthus emblicaLinn.,therefore it is carried out for the beneficial effects of human 
use.  
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2 AIM AND OBJECTIVE
 
 
1. Extraction of active constituents present in the fruits of Phyllanthus emblica 
Linn., using distilled water : ethanol (70:30) by cold maceration method. 
 
2. Evaluation of in vivo anti-anaemic activity on Streptozotocin induced adult 
wistar rats. 
 
3. Evaluation of haematological parameters such as  
 
 RBC count 
 Haemoglobin level 
 Packed cell volume 
 Mean cell volume 
 Mean cell haemoglobin 
 Mean cell haemoglobin concentration 
 Red cell distribution width 
 
4. Red Blood Cell morphological studies. 
 
 Variation in the size of RBC 
 Variation in the shape of RBC 
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3 REVIEW OF LITERATURE 
 
Antidiarrheal and Antispasmolytic activities  
Malik Hassan Mehmood et al., 2011 was evaluated about the crude 
extract of Phyllanthus emblica for its constituents like alkaloids, tannins, 
terpenes, flavonoids, sterols and coumarins and it causes the inhibition of castor 
oil-induced diarrhea and intestinal fluid accumulation in mice at the dose of 
500–700mg/kg. These results indicate that the Phyllanthus emblica fruit extract 
possessed antidiarrheal and spasmolytic activities mediated possibly through 
dual blockade of muscarinic receptors and Ca
2+
 channels 
[21]
. 
Antioxidant activity in Pregnancy 
Ragini Sharma et al., 2015 was stated that Emblica officinalis (Amla) 
is having good antioxidant effect and have lactating properties so it is  beneficial 
to improve health of young ones when their mothers are fed with this plant 
product during pregnancy and lactation. During pregnancy there are more 
possibilities to generate free radicals which cause various metabolic disorders. 
To avoid side effects of free radicals during pregnancy women should take 
products with plenty of antioxidants and little deleterious impact. Amla fruit is 
versatile product with pharmaceutical and therapeutic properties. This study 
proved that Emblica officinalis is beneficial during pregnancy and lactation
 [22]
. 
Antimutagenicity 
D. Madhavi et al., 2007 was investigated about the protective effect of 
Phyllanthus emblica against clastogenicity induced by lead nitrate on the 
incidence of sperm head abnormalities in the germ cells of mice. At higher 
concentration of lead, a significant increase in the percentage of sperm head 
abnormalities was noted.  But when the animals are treated with Phyllanthus 
fruit extract there was a reduction in the frequency of sperm head abnormalities 
is observed. It can be suggested from this study Phyllanthus emblica plays a key 
role in inhibition of heavy metal mutagenesis in mammals 
[23]
. 
Antihyperlipidemia 
B Antony et al., 2012 was labelled that two doses of AmlamaxTM 
(purified, standardized, dried extract of amla) were evaluated 500 and 1000mg 
per day for 6 months. Blood samples were collected at the 3
rd 
and 6
th
 months 
showed reduction in total LDL cholesterols and enhancement of beneficial HDL 
cholesterol. In addition, blood CRP levels, a marker for inflammation, were also 
significantly reduced. Since hyperlipidemia is the two major component of 
cardiovascular diseases, the present study must be considered encouraging and 
indicate the potential of AmlamaxTM in the management of heart diseases 
[24]
. 
Anti-inflammatory activity 
Dang GK et al., 2011 was studied about two models of acute 
inflammation, namely carrageenan induced rat paw oedema and acetic acid 
induced peritonitis in mice. In the model of carrageenan induced paw oedema 
Phyllanthus emblica showed a trend to reduce the oedema. Whereas in a model 
of acetic acid induced peritonitis Phyllanthus emblica showed a significant 
decrease in the protein content of the peritoneal exudates compared with the 
disease control group 
[25]
. 
 
 
Anti-tumour activity 
Jose JK et al., 2001 was evaluated that aqueous extract of Emblica 
officinalis (E.O) was found to be reduce solid tumours in mice induced by DLA 
cells. Animals treated with E.O extract increases the life span of tumour bearing 
animals (20%). E.O extract was found to inhibit cell cycle regulating enzymes 
cdc-25 phosphatase in a dose dependent manner. The results suggest that anti-
tumour activity of E.O extract may partially be due to its interaction with cell 
cycle regulation 
[26]
. 
Memory enhancing activity 
Vasudevan M et al., 2007 was studied about memory enhancing 
activity of Anwala churna (Ayurvedic preparation of Emblica officinalis) on 
memory, and brain cholinesterase activity in mice. Diazepam and scopolamine 
are used to age-induced amnesia. Anwala churna was administered for fifteen 
days to different groups of young and aged mice. Elevated plus maze and 
passive avoidance apparatus served as the behavioral models for testing 
memory. Anwala churna produced a dose-dependent improvement in memory 
scores of young and aged mice. Furthermore, it reversed the amnesia induced by 
scopolamine and diazepam. Anwala churna may proved to be a useful remedy 
for the management of Alzheimer's disease on account of its multifarious 
beneficial effects such as, memory improving property and anticholinesterase 
activity 
[27]
. 
 
 
 
Ophthalmic disorders 
Biswas NR et al., 2011 was conducted an open prospective multi 
centre clinical trial in patients suffering from various ophthalmic disorders like 
conjunctivitis, conjunctival xerosis (dry eye), acute dacryocystitis, degenerative 
conditions (pterygium or pinguecula) and postoperative cataract patients with a 
herbal eye drop preparation (Ophthalcare). Ophthal care include Carum 
copticum, Terminalia belirica, Emblica officinalis, Curcuma longa, Ocimum 
sanctum, Cinnamomum camphora, Rosa damascena and Meldespum apum.  An 
improvement was observed with the treatment of the herbal eye drop treatment 
in most cases. There were no side effects observed during the course of the 
study and the eye drop was well tolerated by the patients 
[28]
. 
Antidiabetic activity 
Mai A Elobeid et al., 2015 was studied about the anti hyperglycemic 
effect of the aqueous fruit extract of amla. Diabetes was induced by 
streptozotocin injection at the dose of 45mg/kg. Untreated diabetic control 
(group 1) received 2 % gum acacia as vehicle; groups 2 and 3 were diabetic rats 
administered the fruit extract in 400 and 200 mg/kg doses, respectively; while 
group 4 (diabetic rats) received metformin (600 mg/kg) as reference drug. The 
parameters assessed weekly were body weight, as well as fasting blood glucose, 
cholesterol and triglyceride levels in venous blood. Both plant extract-treated 
groups showed significant reduction in blood glucose levels, cholesterol and 
triglyceride levels, respectively, similar to the metformin treated group. This 
study also stated that the anti-diabetic activity of the aqueous extract of E. 
officianalis showed a better potential than metformin 
[29], [30]
. 
Immunomodulatory effect 
Singh MK et al., 2013 was studied the protective effect of amla against 
thymocytes in mice. Mice were exposed to arsenic induced oxidative stress and 
apoptosis. The antioxidant enzyme assays were carried out using 
spectrophotometer and generation of ROS, apoptotic parameters, change in cell 
cycle were carried out using flow cytometer following the standard protocols. 
Arsenic exposure to mice caused a significant increase in the lipid peroxidation, 
ROS production and decreased cell viability, levels of reduced glutathione, the 
activity of superoxide dismutase, catalase, cytochrome c oxidase and 
mitochondrial membrane potential in the thymus as compared to controls. Co-
treatment with arsenic and amla decreased the levels of cell viability, levels of 
antioxidant enzymes, cytochrome c oxidase and mitochondrial membrane 
potential as compared to mice treated with arsenic alone. The results was proved 
that arsenic induced oxidative stress and apoptosis significantly protected by co-
treatment with amla that could be due to its strong antioxidant potential 
[31]
. 
 Skin disorder 
 Vitiligo 
Colucci R et al 2016 was studied about the repigmenting effects of 
Phyllanthus emblica (P.E) in vitiligo treatment. Sixty-five human subjects were 
treated with one tablet of an oral supplement containing Phyllanthus emblica 
After a 6 months follow-up, a significantly higher number of patients in group 
A had a mild repigmentation on the head/neck regions and on the trunk. This 
result reported that the supplement with Phyllanthus emblica increases the 
effectiveness in patients with vitiligo 
[32]
. 
 Melasma 
Costa A et al., 2010 was studied about the clinical efficacy and safety 
of the Phyllanthus emblica compared to Hydroquinone 2%, in the treatment of 
melasma.  50 volunteers (89%), 23 in Group A and 27 in Group B was 
concluded the study. Two volunteers in Group A and seven volunteers in Group 
B had mild skin adverse events. Depigmentation was observed with the use of 
Phyllanthus emblica it is a safe and efficient alternative for the treatment of 
melasma 
[33]
. 
Antiarthritic activity 
Venil N et al., 2007 was performed an in vitro study to measure the 
chondroprotective effect of  P. emblica („Amalaki‟) fruits by cartilage 
degradation. The in vitro model was setup with explant cultures of articular knee 
cartilage from osteoarthritis patients. Cartilage damage was assayed by 
measuring glycosaminoglycan release from explants treated with P. 
emblica   fruit powders. Aqueous extracts of fruits of Phyllanthus emblica 
powders significantly inhibited the activities of hyaluronidase and collagenase 
in in vitro study. This study is performed to identify the chondro protective 
activity of P. emblica fruits and it was found to be possess antiarthritic activity 
[34]
. 
 Anticoagulant 
Rao TP et al., 2013 was reported that the amla fruit extract potentially 
reduce the  lipo polysaccharide (LPS)-induced tissue factor expression and von 
Wille brand factor release in human umbilical vein endothelial cells (HUVEC). 
In addition, the in vivo anti-inflammatory effects were evaluated in a LPS-
induced endotoxaemia rat model. Oral administration of the amla fruit extract 
(50mg/kg body weight) significantly decreased the concentrations of pro-
inflammatory cytokines, TNF-α and IL-6 in serum. These results suggested that 
amla fruit extract may be an effective anticoagulant and anti-inflammatory 
agent 
[35]
. 
Prokinetic, laxative and spasmodic activities 
Mehmood MH et al., 2013 was evaluated crude extract of the dried 
fruits of Phyllanthus emblica (P.E.) and its fractions were tested positive for the 
prokinetic and laxative activities in mice.  In isolated guinea-pig ileum and 
rabbit jejunum, the crude extract and its aqueous fraction (P.E.) caused 
concentration-dependent and partially atropine-sensitive stimulatory effects 
followed by relaxation at higher tested concentrations, being more efficacious in 
guinea pig, while more potent in rabbit tissues. This study showed that 
the Phyllanthus emblica possessesd prokinetic and laxative activities in mice 
along with spasmodic effect in the isolated tissues of guinea pig and rabbit, 
mediated partially through activation of muscarinic receptors. This study also 
provides a rationale for the medicinal use of Phyllanthus emblica fruits in 
indigestion and constipation 
[36]
. 
Radioprotective effect 
Jindal A et al., 2009 was studied about the radioprotective effect of 
Emblica officinalis extract (EOE) in mice. Swiss albino mice were exposed to 
gamma rays to produce toxicity.  Then EOE is orally administered at the dose of 
100 mg/kg body weight once daily for 7 consecutive days. A specimen of small 
intestine (jejunum) was removed from the mice and studied at different autopsy 
intervals from 12 hours to 30 days. The animals receiving EOE prior to 
irradiation had a higher number of crypt cells and mitotic figures when 
compared with non-drug-treated control at all the autopsy intervals. Irradiation 
of animals resulted in a dose-dependent elevation in lipid peroxidation and        
a reduction in glutathione as well as catalase concentration in the intestine           
at 1 hour post-irradiation. In contrast, EOE treatment before irradiation caused   
a significant depletion in lipid peroxidation and elevation in glutathione and 
catalase levels and showed significant radioprotective effect
[37]
. 
Wound Healing Activity 
Hema Sharma Datta et al., 2011 was evaluated the wound healing 
activity in rats. In this study the parameters studied are including wound 
contraction, collagen content and skin breaking strength which in turn an 
indicative of the tissue cell regeneration capacity, collagenation capacity and 
mechanical strength of skin. The group treated with the formulations 
containing Phyllanthus emblica showed significantly better wound contraction, 
higher collagen content and better skin breaking strength when compared to 
control group. Phyllanthus emblica was found to possess   wound healing 
activity 
[38]
. 
Antisnake venom activity 
Alam MI et al., 2003 evaluate the antisnake venom activity of 
methanolic root extracts of  Vitex negundo Linn and  Emblica officinalis.         
E. officinalis extracts significantly antagonized the Vipera russellii and Naja 
kaouthia venom induced lethal activity in in vitro and in vivo studies.               
V. russellii venom-induced haemorrhage, coagulant, defibrinogenating and 
inflammatory activity was significantly neutralized by both plant extracts.       
No precipitating bands were observed between the plant extract and snake 
venom. This study confirmed that methanolic root extracts 
of Emblica officinalis possessd potent snake venom neutralizing capacity 
[39]
. 
Anti epileptic 
Golechha M et al., 2011 was evaluated the anti epileptic activity of 
hydro alcoholic extract of Emblica officinalis fruit (HAEEO) in rats. Seizure 
was induced by the administration of kainic acid (KA) and observed for 
behavioral changes, incidence, and latency of convulsions over 4 hours. The rats 
were thereafter sacrificed for estimation of oxidative stress parameters such as 
thiobarbituric acid-reactive substances (TBARs) and glutathione (GSH). The 
pro inflammatory cytokine tumor necrosis factor alpha (TNF-α) was also 
determined in the rat brain. Pre treatment with HAEEO significantly increases 
the latency of seizure TNF-α level in the brain and prevented the increase in 
TBARS levels and ameliorated the fall in GSH. These reports stated that 
Emblica officinalis fruit possess efficient anti epileptic activity 
[40]
. 
 Arsenic toxicity in water 
Sayed S et al., 2015 was conducted an experiment to evaluate the 
protective effects of Phyllanthus emblica leaf extract (PLE) on arsenic-mediated 
toxicity in mice. Male Swiss albino mice were divided into three different 
groups (n=6/group). 'Control' mice received arsenic free water together with 
normal feed. Mice in the remaining two groups designated 'SA' and 'SA+PLE' 
were exposed to sodium arsenite (SA) through drinking water in addition to 
receiving normal feed and PLE-supplemented feed, respectively. The weight 
gain of SA-exposed mice was decreased compared with the controls.  A 
secondary effect of arsenic was enlargement of the liver, kidney and spleen was 
observed in SA-group mice. In PLE supplemented mice the enlargement of the 
organs was minimized and the deposition of arsenic was not significantly 
reduced. PLE may not block arsenic deposition in tissue directly but rather may 
play a protective role to reduce arsenic-induced toxicity 
[41]
.  
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Figure 2 Fruits of Phyllanthus emblica Linn., 
 
 
 
 
                   
 
 
 
 
 
 
 
  PLANT PROFILE 
 
Botanical name              : Phyllanthus emblica L. 
Synonym                        : P. Mairei, Emblica officinalis Gaertn., P. Taxifolius D. Don 
Family                            : Phyllanthaceae 
[42] 
 
Toxonomical classification 
[19], [44] 
Kingdom                          :  Plantae  
Order                                :  Malpighiales  
Family                              : Phyllanthaceae 
Genus                               :  Phyllanthus  
Species                             :  P. emblica   
Botanical name                :  Phyllanthus emblica L. 
Synonyms                        :  P. Mairei, Emblica officinalis Gaertn.,                  
                                                P. taxifolius D.   Don 
Vernacular names 
[43], [19] 
 Sanskrit           :  Dhatriphala, Amla, Amaliki, Amalakan 
 Tamil                :   Nellikai 
 Hindi           :  Amla 
 English         : Emblica myroblan 
 Telugu            : Rasi usiri 
 Malayalam    :  Nelli 
 Oriya      :  Anlaa 
 Punjabi     : Aula  
 Description
 
Phyllanthus emblica is small to medium sized, reaching 8 to 18 m in height, 
with a crooked trunk and spreading branches. The branch lets are glabrous or finely 
pubescent, 10-20 cm long, usually deciduous. The leaves are simple, sub sessile and 
closely set along branch lets, light green, resembling pinnate leaves. The flowers are 
greenish-yellow. The fruit is nearly spherical, light greenish yellow, quite smooth and 
hard on appearance, with 6 vertical stripes or furrows. Ripening in autumn, the berries 
are harvested by hand after climbing to upper branches bearing the fruits. The taste of 
Indian gooseberry is sour, bitter and astringent, and is quite fibrous
 [44]
.  
Habitat and Cultivation 
 It is a potential crop which grows in marginal soils and various kinds of 
degraded lands such as salt-affected soils, dry and semi-dry regions.  Found wild and 
cultivated in all parts of India, especially the south, to an altitude of 1500 m. Although 
it is native to India, also grows in tropical and subtropical regions of Pakistan, 
Uzbekistan, Sri Lanka, South East Asia, China, Malaysia, Indonesia, Peninsula, 
Burma and Ceylon 
[45][46]
. 
Parts used 
 Fresh and dried fruit, seed, leaf, root, bark and flower
 [19]
. 
Chemical constituents 
 Tannins 30%, phyllembin (2.4%), phyllemblic acid (6.3%), gallicacid 
(1.32%), ellagic acid in natural form and cytokine like substances identified as Zeatin, 
Z riboside, Z nucleotide etc. Amla is a rich natural source of vitamin C. It contains 
pectin & 75% moisture. Amla fruit ash contains chromium 2.5, zinc 4 and             
copper 3 ppm 
[19] [43]
. 
 Traditional uses 
[19] 
 Reduces fever and cough 
 Purifies the blood 
 Stimulate hair growth 
 Enhances the digestion 
 Used in inks, shampoos and hair oils. 
Medicinal uses 
[43] [19] 
 Decoction prepared of dried fruit in new earthen vessel is used for eye 
wash in ophthalmic diseases.   
  The exudate collected from incisions made on the fruit is applied 
externally on inflammation of the eye.  
  Fermented liquor prepared from the fruit is used in jaundice, dyspepsia 
and cough.  
  Paste of the fruit is a useful external application over the pubic region 
in irritability of the bladder.   
  Fruits are used as an expectorant, an antidote to mineral poisons, 
particularly vermillion and sulphur.  
  Fruit with seeds used for asthma, bronchitis and biliousness.  
  Amla juice with turmeric powder and honey is beneficial in diabetes 
insipidus.   
  In Persia the juice of the fruit is used as a vermifuge.  
  In Tibetan medicine, the fruit have been used as anti pyretic, anti 
inflammatory and anti-diuretic.  
  Indonesians used this fruit for the treatment of dysentery, diarrhoea, 
cholera and biliary disorders.  
  The pulp of the fruit is smeared on the head to dispel headache and 
dizziness.  
  In Turkistan the fresh fruit is used in inflammation of the lungs. 
  Juice of the fruit along with other ingredients is used to cure cough, 
hiccough, asthma as well as fits and insanity.  
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4 SCOPE AND PLAN OF WORK 
 Anaemia is the blood disorder characterized by reduction in the total number 
of red blood cells,   hemoglobin concentration and packed cell volume. In 
India, anaemia became the major public health challenge that attacks 
preschool children and women at reproductive age. In 2002-2004-DLHS 
(District Level Health Service) reported that, 98% of adolescent girls and 96% 
of pregnant women are suffered from anaemia. In 2005-2006- NFHS 
(National Family Health Survey) reported that 24% of men are also found to 
have anaemia due to low level of hemoglobin than normal level
[5]
. 
 Recent studies are shows that herbal drugs are good source of alternative 
therapy which has lesser side effects compared to the conventional system of 
medicine. 
 Medicinal plants play a major role in anti-anaemic activity and their anti 
oxidant action is mediated through inhibition of reactive oxygen species. 
 The fruits of PhyllanthusemblicaLinn., was selected for the study of anti-
anaemic activity as there are traditional claims to treat anaemia. The literature 
review shows that various works on the fruit.   But no scientific work has been 
published on streptozotocin induced anaemic rats so far. 
 Hence the present study attempts to study the anti-anaemic activity on the 
fruits of Phyllanthus emblia Linn., 
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5MATERIALS AND METHODS 
 
1. Collection and identification of plant material 
The fruits of Phyllanthus emblica Linn. were collected from the garden  in 
Namakkal district, Tamil Nadu in the month of Augest, 2015. The plant was identified 
and authenticated by Prof. Sasikala Ethirajulu, Botanist, Siddha Central Research 
Institute, Arumbakkam, Chennai-600106. 
2. Preparation of plant extract 
Chemicals 
 Analytical grade of ethanol and distilled water were bought from Microfine 
Chemicals, Chennai. 
Maceration 
 The fruits were washed under the tap water, shade dried at room temperature 
and then subjected to size reduction to a coarse powder by using wiley mill. The 
powdered fruit material was placed in a stoppered container with distilled water and 
ethanol at the ratio of 70:30 in a room temperature for a period of at least 7 days with 
frequent agitation until the soluble matter has dissolved. The mixture then is strained, 
the marc is pressed, and the combined liquids are clarified by filtration or decantation 
after standing. The aqueous extract was concentrated in a rotary evaporator. The 
concentrated extract was taken for the in vivo studies. 
 
 
Table No: 1 Percentage yield from the aqueous extract of                 
Phyllanthus emblica Linn., 
 
 
Extract 
 
 
Plant 
material 
used 
 
 
Weight of the 
plant 
material(g) 
 
Yield  
(g) 
 
Percentage  
yield(%) 
Distilled water: 
ethanol (70:30) 
Dried 
fruits 
 
250 
 
7 
 
17.5 
 
3. Screening of anti-anaemic activity 
3.1 Experimental animals 
Healthy wistar rats (150-200g) were bought from Animal Experimental 
Laboratory, Madras Medical College, Chennai-03. The study was approved by 
Institutional Animal Ethics Committee which is certified by the Committee for the 
Purpose of Control and Supervision of Experiments on Animals (CPCSEA), India. 
Approval Number:02/243 CPCSEA dated on 10.08.2015 
3.2 Maintenance of animals 
The animals were kept in clean and dry polypropylene cages with stainless 
steel top grill having facilities for pelleted food and water. The animals were 
maintained in a well ventilated animal house in 12 hours and 12 hours dark cycle at a 
temperature of 28
o
C ± 2
o
C and they were acclimatized to laboratory conditions for 10 
days prior to the commencement of the experiment. The animals fed with standard 
pellet diet and water ad libitum. All animal experiments were performed according to 
the ethical guidelines suggested by Institutional Animal Ethics Committee (IAEC). 
Paddy husk was used as bedding material and changed twice a week
[47]
. 
3.3 Animal model
 
The model used to evaluate the anti-anaemic activity was Streptozotocin
[48]
 
induced anaemia in rats
[49]
. 
Streptozotocin induced anaemia in rats  
Streptozotocin was bought from Microfine Chemicals, Chennai. All the 
chemicals used in the study were of analytical grade. 
 
 Procedure 
Anaemia is induced in rats by administration of Streptozotocin for 7 days 
at the dose of 45mg/kg, intraperitoneally. All the animals were weighed and divided 
into four groups, each group containing six animals
[49][29]
. 
Table No: 2 Study Design 
S. No Group Name of the 
group 
Dose No. of 
animals 
Duration of 
dosage 
1 I Control Nil 6 7 weeks 
2 II Streptozotocin 45mg/kg 6 1 week 
3 III Streptozotocin+ 
Vit C 
150kg/kg 6 6 weeks 
4 IV Streptozotocin+ 
water extract 
500mg/kg 6 6 weeks 
5 Total 24 
 
7 weeks 
 
 
The blood samples to be collected before and after the induction of anaemia 
by retro orbital sinus with glass capillary tube and used for the estimation of 
haematological parameters
[50]
. Then the blood was allowed to clot for 30 minutes at 
room temperature. The clear serum was separated by centrifugation at 2500 rpm for 5 
minutes and used for the RBC morphology studies
[51]
. 
 
 Parameters evaluated 
 Haematological analysis 
 Red Blood Cell Volume (RBC) 
 Haemoglobin (HB) 
 Packed Cell Volume (PCV) 
 Mean cell volume (MCV) 
 Mean cell haemoglobin (MCH)  
 Mean cell haemoglobin concentration (MCHC) 
 Red cell distribution width (RDW) 
 
  RBC morphology 
 Variation in the size of RBC 
 Variation in the shape of RBC 
 
 Statistical analysis 
The results of the haematological estimations were presented as 
mean ± SD of six animals in each group. Total variations, present in a set of data were 
estimated by One Way Analysis Of Variance (ANOVA). P value of <0.05 was 
considered statistically significant. 
A. Haematological analysis 
Hematology analyzers are used widely in patient and research settings to count 
and characterize blood cells for disease detection and monitoring
[52]
. Basic analyzers 
return a complete blood count (CBC) with a three-part differential white blood cell 
(WBC) count
[52]
. Sophisticated analyzers measure cell morphology and can detect 
small cell populations to diagnose rare blood conditions
[53]
. 
Figure 3shows XP-100 hematology analyzer 
 
 
 
 
Principles of measurement 
 Blood is   sampled, diluted and moves through a tube thin enough that cells 
pass by one at a time. Characteristics about the cell are measured using lasers 
(fluorescent flow cytometry)or electrical impedence. Because not everything about 
the cells can be measured at the same time, blood is sampled into a number of 
different channels.   
The three main physical technologies used in hematology analyzers are: 
electrical impedance, flow cytometry, and fluorescent flow cytometry. These are used 
in combination with chemical reagents that lyse or alter blood cells to extend the 
measurable parameters
[52]
. 
Electrical impedance 
The traditional method for counting cells is electrical impedance, also known 
as the Coulter principle. It is used in almost every hematology analyzer. Whole blood 
is passed between two electrodes through an aperture so narrow that only one cell can 
pass through at a time. The impedance changes as a cell passes through. The change 
in impedance is proportional to cell volume, resulting in a cell count and measure of 
volume. Impedance analysis returns CBCs and three-part WBC differentials 
(granulocytes, lymphocytes, and monocytes) but cannot distinguish between the 
similarly sized granular leukocytes: eosinophils, basophils and neutrophils. Counting 
rates of up to 10,000 cells per second can be achieved and a typical impedance 
analysis can be carried out in less than a minute
[53]
. 
 
Flow cytometry 
Laser flow cytometry is more expensive than impedance analysis, due to the 
requirement for expensive reagents, but returns detailed information about the 
morphology of blood cells. It is an excellent method for determining five-part WBC 
differentials. A single-cell stream passes through a laser beam. The absorbance is 
measured and the scattered light is measured at multiple angles to determine the cell‟s 
granularity, diameter and inner complexity. These are the same cell morphology 
characteristics that can be determined manually from a slide
[53]
. 
Fluorescent flow cytometry 
Adding fluorescent reagents extends the use of flow cytometry to measure 
specific cell populations. Fluorescent dyes reveal the nucleus-plasma ratio of each 
stained cell. It is useful for the analysis of platelets, nucleated RBCs, and 
reticulocytes. 
Abbott Sapphire, Siemens Advia 120, Beckman Coulter DxH 800, and 
Sysmex XE-2100 are the mostly used CBC analyzers
[54]
. 
Procedure 
The caps are left on the tubes as they go through the machine. A piercer takes 
a sample through the rubber centre while the tube is upside down. EDTA (lavender) 
tubes are usually used, although citrate (blue top) tubes will also work (although the 
result must be corrected because of dilution)
[55]
. 
 
Range of tests 
Every haematology analyzer returns a CBC and a three- or five-part WBC 
differential. However, even the simplest analyzer will return multiple parameters. The 
most basic analyzer from Sysmex is the XP-100. It returns 20 parameters: WBC, 
RBC, HBB, HCT, MCV, MCH, MCHC, PLT, NEUT %, LYM%, MXD%, RDW-SD, 
RDW-CV,MXD, MPV, PCT, NEUT#, LYM# , P-LCR and MXD#
[52][56] 
Time per analysis 
 Time per analysis depends on the parameters being measured. A simple CBC 
can typically be returned in 1 min. More sophisticated analyses can take up to 10 min. 
Sample size and micro sampling 
 Sample size requirements are on the order of 150μL of whole blood for 
multiparameter analysis. Many manufacturers offer micro sampling, which is 
particularly helpful for pediatrics. The Horiba ABX Micros ES 60 uses 10μL of whole 
blood for CBC plus WBC 3-differential
[52]
. 
Accuracy, precision and linearity 
The accuracy of volume measurements using electrical impedance can be 
greater than 1% and depends on the width of the aperture relative to the cell being 
measured. Some instruments use multiple-sized apertures to improve accuracy for 
different-sized cells. Temperature also affects accuracy. The Horiba Pentra 80 
features a preheated analysis chamber to ensure consistent results
[52]
. 
 
Open or closed tube sampling 
Closed tube sampling reduces the risk of exposure to blood. Instruments with 
open or closed sampling options have different stability and calibration requirements 
depending on the mode of operation. 
Results storage and analysis 
A major differentiator between analyzers is the number of results that can be 
stored on the system. A small benchtop analyzer might typically save 1000 patient 
results with histograms. The Horiba ABX Pentra DX120 SPS will store 90,000 results 
plus graphics
[52]
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. RBC Morphology 
 
Normal and Pathologic Red Blood Cells 
The normal red blood cell is a biconcave disk, 6 to 9μm in diameter and 1.5 to 
2.5 μm thick. The haemoglobin imparts a uniform pink to orange-red color to the 
cytoplasm that is typically without inclusions
[2]
. Normally all red blood cells are 
relatively uniform in size and shape. Numerous disease states affect the size, shape 
and haemoglobin content of red cells. Variation in size is referred to as 
“anisocytosis,” and variation in shape is termed “poikilocytosis.” Pathologic red cells 
may be larger or smaller than normal, may be abnormally shaped, or may contain 
inclusions
[57][59]
. 
 
 Procedure 
 1ml of blood will be collected from rat eye by sinus orbital puncture and 
centrifuged at 2000rpm for 5mins and the plasma was discarded.  
 The packed cells are reconstituted as 10% v/v suspension with 0.9% normal 
saline
[57]
.  
 A Drop of this suspension will be put on a glass slide under a cover slip and 
studied under High Power Microscope at 40 X for assessment of morphological 
changes in the red blood cells
[57]
.  
 
 
 
Morphological changes in RBC‟s at 0thday, after induction of anaemia and 
after 6 weeks of treatment with amla aqueous extract will be assessed using the 
following scoring pattern
 [60]
 
 5-10% abnormal RBC        =0 
 10-25% abnormal RBC = 1+ 
 25-50% abnormal RBC   = 2+ 
 50-75% abnormal RBC =3+ 
 >75% abnormal RBC = 4+ 
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6 RESULTS 
 
Table 3: Haematological parameters after the treatment with aqueous extract of 
Phyllanthus  emblica Linn., at the end of 42days 
 
S. 
NO 
 
PARAMETERS 
 
GROUP I 
 
GROUP II 
 
GROUP III 
 
GROUP IV 
 
1 
 
RBC Count 
(X10
12
/L) 
 
8.98±0.562
 
 
7.23±0.468
a 
 
8.07±0.539
b 
 
7.96±0.396
b 
 
2 
 
Haemoglobin(g/DL) 
 
 
15.76±0.626
 
 
10.15±0.584
a 
 
14.78±0.686
b 
 
13.64±0.842
b 
 
3 
   
Hematocrit(%) 
 
46.85±1.247
 
 
38.13±1.437
a 
 
43.78±0.692
b 
 
41.26±0.725
b 
 
4 
 
Mean Cell Volume (fL) 
 
61.8±0.9927
 
 
49.2±1.434
a 
 
57.6±2.688
b 
 
54.2±1.003
b 
 
5 
 
Mean Cell  
Hemoglobin(pg) 
 
 
19.4±0.612
 
 
16.4±0.55
a 
 
18.2±0.206
b 
 
17.43±0.909
b 
 
6 
 
Mean Cell Hemoglobin 
Concentration(g/DL) 
 
 
37.18±1.592
 
 
31.4±0.864
a 
 
35.4±1.093
b 
 
34.2±0.887
b 
 
7 
 
Red Cell Distribution 
Width(%) 
 
 
14.4±0.493
 
 
10.3±0.917
a 
 
14.0±0.793
b 
 
13.4±0.686
b 
Values are expressed as mean ± SD (n=6). 
‘a’  P<0.001 compared with control group 
‘b’ P<0.001 compared with negative control group 
There is a decrease in RBC count, Haemoglobin level, Hematocrit,  Mean cell 
volume, Mean cell haemoglobin, Mean cell haemoglobin concentration, Red cell 
distribution width after the administration of streptozotocin in negative control group. 
And these levels are increased with the administration of aqueous extract of 
Phyllanthus emblica Linn., treated group and the P values are also significant 
(P<0.001). 
 
Figure 4: RBC count after the treatment with aqueous extract of Phyllanthu 
semblica Linn., at the end of 42 days 
 
 
 
The results are tabulated in Table 3. Anaemic rats showed decrease in RBC 
count whereas the RBC count of the control rats remained the same. Administration 
of Vit C and aqueous extract of fruit of Phyllanthus emblica for 42 days significantly 
(P<0.001) increase the RBC count and brought back RBC count towards normal. 
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Figure 5: Haemoglobin level after the treatment with aqueous extract of 
Phyllanthus emblica Linn., at the end of 42 days 
  
 
 
 
The results are tabulated in Table 3. Anaemic rats showed decrease in Hb 
level whereas the Hb level of the control rats remained the same. Administration of 
Vit C and aqueous extract of fruit of Phyllanthus emblica for 42 days significantly 
(P<0.001) increase the Hb level and brought back Hb level towards normal. 
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Figure 6: Hematocrit after the treatment with aqueous extract of Phyllanthus   
emblica Linn., at the end of 42 days 
 
 
 
 
 
The results are tabulated in Table 3. Anaemic rats showed decrease in 
Hematocrit whereas the Hematocrit of the control rats remained the same. 
Administration of Vit C and aqueous extract of fruit of Phyllanthus emblica for 42 
days significantly (P<0.001) increase the Hematocrit and brought back Hematocrit 
towards normal. 
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Figure 7: Mean Cell Volume after the treatment with aqueous extract of 
Phyllanthus emblica  Linn,.at the end of 42 days 
 
 
 
 
 
The results are tabulated in Table 3. Anaemic rats showed decrease in Mean 
Cell Volume whereas the Mean Cell Volume of the control rats remained the same. 
Administration of Vit C and aqueous extract of fruit of Phyllanthu semblica for 42 
days significantly (P<0.001) increase the Mean Cell Volume and brought back Mean 
Cell Volume towards normal. 
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Figure 8: Mean Cell Haemoglobin after the treatment with aqueous extract of 
Phyllanthu semblica Linn., at the end of 42 days 
 
 
 
 
The results are tabulated in Table 3. Anaemic rats showed decrease in Mean 
Cell haemoglobin level whereas the Mean Cell haemoglobin level of the control rats 
remained the same. Administration of Vit C and aqueous extract of fruit of 
Phyllanthus emblica for 42 days significantly (P<0.001) increase the Mean Cell 
haemoglobin level and brought back Mean Cell haemoglobin level towards normal. 
 
 
 
 
 
 
 
14.5
15
15.5
16
16.5
17
17.5
18
18.5
19
19.5
20
GROUP I GROUP II GROUP III GROUP IV
m
e
an
 c
e
ll 
h
ae
m
o
gl
o
b
in
 (
p
g)
 
MEAN CELL HAEMOGLOBIN 
MCH
Figure 9: Mean Cell Haemoglobin Concentration after the treatment with 
aqueous extract of Phyllanthus emblica Linn., at the end of 42 days 
 
 
 
 
 
The results are tabulated in Table 3. Anaemic rats showed decrease in Mean 
Cell Haemoglobin Concentration level whereas the Mean Cell Haemoglobin 
Concentration level of the control rats remained the same. Administration of Vit C 
and aqueous extract of fruit of Phyllanthus emblica for 42 days significantly 
(P<0.001) increase the Mean Cell Haemoglobin Concentration level and brought back 
Mean Cell Haemoglobin Concentration level towards normal. 
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Figure 10: Red Cell Distribution Width after the treatment with aqueous extract 
of Phyllanthus  emblica  Linn.,at the end of 42 days 
 
 
 
 
 The results are tabulated in Table 3. Anaemic rats showed decrease in Red 
Cell Distribution Width whereas the Red Cell Distribution Width of the control rats 
remained the same. Administration of Vit C and aqueous extract of fruit of 
Phyllanthus emblica for 42 days significantly (P<0.001) increase the Red Cell 
Distribution Width and brought back Red Cell Distribution Width towards normal. 
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Figure 11: Morphology of RBC at 0 day 
 
                                  
 
                       
 
 The morphology of RBC was observed on 0 day. All the cells are in 
same size and shape when focused under the microscope. 
 
 
 
 
 
Figure 12: Morphology of RBC after the administration of Streptozotocin. 
 
                    
 
                         
 
 
The morphology of RBC was observed on 7
th
day of Streptozotocin 
administration. Heinz bodies were observed with crenated edges and changes in the 
shape of red blood cells were observed.  
 
 
 
 Figure 13: Morphology of RBC after the administration of aqueous extract of 
Phyllanthus  emblicaL inn., for 42 days. 
 
                              
 
 
                         
 
 
There is a reduction in the number of Heinz bodies after the administration of 
aqueous extract of Phyllanthus emblica Linn.for 42 days. 
 
 
Figure 14: Percentage of destroyed RBC after the administration of 
Streptozotocin. 
 
 
 
 
About 91% of red blood cells were affected with the administration of 
Streptozotocin and presence of Heinz bodies with crenated edges were observed. 
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Figure 15: Percentage of the normal RBC after the administration of aqueous 
extract of Phyllanthus emblica Linn. at the end of 42 days. 
 
 
 
 About 70% of Heinz bodies were treated with the administration of 
Phyllanthus emblica Linn., for 42 days and become to its normal shape and the results 
showed that Phyllanthus emblica prevents the destruction of RBC. 
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Discussion 
 
 
 
 
 
 
 
 
 
 
 
  
7 DISCUSSION 
Anaemia is considered as a major health problem throughout the world. 
Anaemia is a condition in which there is a deficiency of red blood cells or of 
haemoglobin in the blood, resulting in pallor and weariness. More than half of the 
world‟s population experience some forms of anaemia in their life time. The 
incidence of anaemia is higher in the third world than in developed countries
[61]
. 
Such prevalence has been attributed to various aggravating factors such as 
poor nutrition, pregnancy, high prevalence of blood parasites for example, 
plasmodium, trypanosome and helminthes infection. Prolonged use of non-steroidal 
anti-inflammatory drugs as well as exposure to toxic chemicals such as phenyl 
hydrazine have also been implicated to cause anaemia. Due to the high prevalence and 
possibility of even further increase, there is the need to prevent it or seek for more 
cost effective and better treatment strategies
[61][65]
.  
From ancient time, medicinal plants in Ayurveda are believed to be useful in 
strengthening the hematopoietic and immune system of an individual. Ayurvedic 
physicians suggested various herbs for the treatment of haematological disorders as a 
source of iron and other minerals
[62][19] 
Various researchers successfully evaluated the potential of several medicinal 
plants in the treatment of anaemia using various experimental animal models. 
Ageratum conyzoides, Boerhavia diffusa, Centella asiatica, Hemide  smusindicus, 
Ichnocarpus frutescens, Momordica charantia, Moringa oleifera, Phyllunthus 
amarus, Punica granatum, Ocimum tenuiflorum, Solanum americanumare the some 
plants used in the treatment of anaemia
[63][64][65][66][71]
. 
 Phyllanthus emblicais traditionally used in ayurveda to treat fever, 
inflammation peptic ulcer. Analgesic, digestive, hair tonic diuretic, anti tussive, cardio 
protective, chemo preventive, free radical scavenging activity, antimutagenic, cancer, 
antidiabetic
[19][20]
. 
The Phytochemical analysis of aqueous extract of fruits of Phyllanthus 
emblica  revealed the presence of tannins, alkaloids,  ascorbic acid, phyllembin, 
phyllemblic acid, gallicacid, ellagic acid and also minerals like iron and zinc 
[19]
.  
To induce anaemia in the wistar rats are administered to Streptozotocin 
45mg/kg by intraperitonially for seven days,
[48]
on the 8
th
 day the blood was collected 
and haematological studies are performed then the blood was centrifuged and the 
serum was separated and used for the RBC morphology studies. 
HAEMATOLOGICAL STUDY 
RBC count 
The normal RBC count in wistar rat is 10.12-16.6X10
12
/L. After seven days of 
Streptozotocin administration the RBC count was reduced to 7.23X10
12
/L because of 
the destruction of RBC. The destruction of red blood cells is maybe due to the 
presence of oxidative stress
[10]
. This reduced RBC count was increased after the 
treatment of aqueous extract of Phyllanthus emblica.  
Haemoglobin level (Hg) 
There is a significant reduction in haemoglobin level of animals after the 
administration of Streptozotocin. The haemoglobin level is fall from 15.7 to 10.2g/DL. The 
reduced haemoglobin level shows the presence of anaemia in animals after the 
administration of aqueous extract of Phyllanthus emblica Linn., the haemoglobin 
level is increased upto 13.6g/DL. 
Hematocrit (HCT) 
It is also called as packed cell volume. It is the volume of packed red cells 
obtained after centrifugation of sample of anti-coagulated venous or capillary blood. 
After the induction of anaemia the hematocrit was reduced to 38.13% which is lower 
than the normal value and this reduction proved the presence of anaemia. There is a 
significant increase in PCV volume after treating the animals with aqueous extract of 
Phyllanthus emblica Linn., and the PCV was increased upto 41.26% . 
Mean cell volume (MCV) 
 It is also called as mean corpuscular volume. It represents the average volume 
of a single red cell, and it expressed in femtolitres. There is a change in MCV volume 
in before and after the treatment with the Phyllanthus emblica. The reduced MCV 
volume by the administration of streptozotocin was improved by the Phyllanthus 
emblica Linn., 
Mean corpuscular haemoglobin (MCH) 
It is the average amount of haemoglobin in each red cell and expressed in 
picograms. There is a low MCH volume is observed in negative control group by the 
administration of streptozotocin and results in microcytic hypochromic canaemia. 
This value is increased by the administration of aqueous extract of Phyllanthus 
emblica Linn., 
 
 
Mean corpuscular haemoglobin concentration (MCHC) 
This represents the average concentration of haemoglobin in a given volume 
of packed red cells and it expressed in g/dL. Low MCHC values are observed in the 
negative control group and cause microcytic hypochromic anaemia.  These low 
MCHC values are raised after giving the aqueous extract of Phyllanthus emblica 
Linn., to the animals. 
Red cell distribution width (RDW) 
It is the degree of variation of red cell size and can be determined on some 
blood cell analyzers. The comparision of negative and treatment group shows 
different values because the aqueous extract of Phyllanthus emblica Linn., increases 
the Red cell distribution width. 
In this haematological study the reduced MCV, MCH, MCHC and RDW were 
observed, these reductions may be due to the oxidative stress caused by the 
administration of Streptozotocin and also there is a marked reduction in RBC count, 
Hg and HCT.This study also proves the presence of anaemia in  Streptozotocin treated 
animal and this effect maybe due to oxidative stress. Administration of Phyllanthus 
emblica Linn., increases the RBC count, Haemoglobin level, Haematocrit, Mean Cell 
Volume, Mean Cell Haemoglobin, Mean Cell Haemoglobin Concentration and Red 
Cell Distribution Width. 
RBC MORPHOLOGY 
 The  normal Red Blood Cells is in the shape of biconcave disk  and the size of 
red blood cells is 6 to 9μm in diameter is 1.5 to 2.5μm thick. Normally red blood cells 
are relatively uniform in size and shape. Pathologic red cells may be larger or smaller 
than normal, may be abnormally shaped, or may contain inclusions.  
 Streptozotocin is a naturally occurring chemical that particularly toxic to the 
animals
[48]
. It induces changes in the red cell membrane, which result in oxidative 
denaturation of Hb. The effect of the denaturation is the formation of an altered Hb 
called “Heinz bodies” which reduces the life span of the erythrocytes[67][11]. Altered 
erythrocytes are removed by the spleen and liver of the reticulo endothelial system 
resulting in compensated haemolytic anemia
[10][11]
. 
 Presences of Heinz bodies are observed in the red blood cells morphology 
after the administration of Streptozotocin in all group except the control group. The 
presence of Heinz bodies with crenated edges furthermore confirms the presence of 
hemolytic anaemia due to the oxidative stress caused by reactive oxygen 
species
[68][69]
. 
Heinz Bodies  
 Heinz Bodies is caused by destruction of haemoglobin and observed as 
inclusions. The Heinz Bodies has round, refractile inclusions found on the periphery 
of the cell
[10]
. It consists of denatured globin produced by the destruction of 
haemoglobin. They may occur due to thalassemia, drug induced anaemia, unstable 
haemoglobinopathies
[12]
. 
 This study proves that Streptozotocin is able to cause anaemia in animals due 
to its oxidative stress. Appearance of Heinz bodies in red blood cell morphology 
proves the presence of anaemia and it maybe a type of hemolytic anaemia
[70] [10]
. 
It also contains phytochemical constituents such as flavonoids, tannins, and 
gallicacid. The value of zinc present in the fruits of Phyllanthus emblica Linn., is 
about 4ppm which has been reported to possess anti-anaemic potentials.
[19]
.  
There is a reduction in the percentage of Heinz bodies after the administration 
of aqueous extract of Phyllanthus emblica Linn., when compared with negative 
control group of animals . Phyllanthus emblica Linn., also increases the RBC count, 
Haemoglobin level, Haematocrit, Mean Cell Volume, Mean Cell Haemoglobin, Mean 
Cell Haemoglobin Concentration and Red Cell Distribution Width. So this result was 
showed that fruits of aqueous extract of Phyllanthus emblicaLinn., found to  
possessed anti-anaemic activity due to the presence of active constituents and also has 
been responsible for reducing oxidative stress. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Conclusion 
 
 
 
 
 
 
 
 
 
   
8 CONCLUSION 
Anaemia is considered to be one of the major health problems especially in 
chronic disorder like diabetes, rheumatoid arthritis, cancer, kidney disease, and HIV. 
According to the World Health Organization, about 30% of people throughout the 
world suffer from anemia. The most common cause of anaemia is iron deficiency. 
In this present study it has been shown that the aqueous extract of Phyllanthus 
emblica Linn., increases the RBC count, Haemoglobin level, Haematocrit, Mean Cell 
Volume, Mean Cell Haemoglobin, Mean Cell Haemoglobin Concentration and Red 
Cell Distribution Width and also improved the hemolytic anaemia induced by 
Streptozotocin in test animals, when compared with the untreated animals in the 
negative control group (Group 2). 
On the basis of the above results the RBC morphological studies, reduction in 
the percentage of Heinz Bodies after the administration of aqueous extract of 
Phyllanthus emblica Linn.,when compared with negative control group (Group 2) of 
animals.  
Hence it was suggested that the fruits of aqueous extract of Phyllanthus 
emblica Linn., possessed significant anti-anaemic effect. This may probably due to 
the anti-oxidant property of Phyllanthus emblica Linn., 
It was showed that Phyllanthus emblicaLinn., contains natural antioxidant and 
possessed anti-anaemic activity  which can be safely used in man.  Further isolation 
and purification of bioactive compound from the fruits of Phyllanthus emblica may 
reveal the presence of potent novel anti-anaemic agent and also to unveil the 
molecular mechanism behind its therapeutic action. 
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